Haleon plc ADR (HLN)
NYSE: HLNConsumer DiscretionaryPackage Goods/CosmeticsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
HLN stock chart
Technical analysisKey statistics
All statistics- Market cap
- $39.76B
- P/E (TTM)
- 18.51
- Forward P/E
- 15.01
- EPS (TTM)
- $0.49
- Dividend yield
- 0.80% ($0.073)
- Ex-dividend date
- Aug 14, 2026
- 52-week range
- 8.38 – 11.28
- Day range
- 9.07 – 9.17
- Volume / Avg
- 17.96M / 19.19M
- Beta
- —
- Shares outstanding
- 4.38B
52-week range
HLN stock today
Shares of Haleon (HLN) finished higher on Nov 20 at $9.07, a gain of 0.22% or $0.02 per share, versus the S&P 500's 3.70% decline. At this level, HLN sits in the middle of its 52-week range of $8.38 to $11.28: 19.6% below the high, set on Feb 18, 2026 and 8.2% above the low. HLN is down 10.3% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 8.1%.
At 18.5x trailing earnings, Haleon trades below the peer-group median of 38.4x. Its forward P/E of 15.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Haleon pays an annual dividend of $0.073 per share, a 0.80% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Haleon
Company profileHaleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues.
- Sector
- Consumer Discretionary
- Industry
- Package Goods/Cosmetics
- CEO
- Mr. Brian James McNamara
- Headquarters
- Weybridge
- Employees
- 24,535
- IPO year
- 2022
- Website
- haleon.com
Analyst forecast
ForecastConsensus (5 analysts)
buy
Avg. price target
$10.40+14.66%
- Strong buy 3
- Buy 0
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Dividends
Dividend history- Annual dividend
- $0.073
- Dividend yield
- 0.80%
- Last payment
- $0.064
- Ex-dividend date
- Aug 14, 2026
HLN news
All HLN news- PG Raises Sales Outlook as Thorne Acquisition Adds Growth PotentialNasdaqPG, CL, HLN
- KMB's Kenvue Deal: Could $2.1 Billion in Synergies Lift Earnings?NasdaqKMB, PG, HLN
- Is KMB Worth Buying as Low Valuation Meets Kenvue Integration Risk?NasdaqKMB, PG, HLN
- ASAIY vs. HLN: Which Stock Is the Better Value Option?Nasdaq
- Haleon plc Announces Purchase of 11,006,678 Ordinary Shares Under Buyback ProgrammeNasdaq
- Haleon: If Staples Hold Up, The Stock Should OutperformSeeking Alpha
- Haleon plc Purchases 12,572,956 Ordinary Shares Under Buyback ProgrammeNasdaq
- Haleon plc Announces Commencement of £500m Share Buyback ProgrammeNasdaq
Haleon peers
Consumer Discretionary sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ELEstee Lauder Companies Inc. (The) | 99.46 | -2.27% | $36.04B | vs HLN |
| CHDChurch & Dwight Company Inc. | 110.84 | +1.06% | $26.16B | vs HLN |
| ELFe.l.f. Beauty Inc. | 103.47 | -5.01% | $6.12B | vs HLN |
| IPARInterparfums Inc. | 137.42 | +3.37% | $4.40B | vs HLN |
| COTYCoty Inc. Class A | 3.95 | -2.47% | $3.48B | vs HLN |
| SCLStepan Company | 63.48 | -2.34% | $1.44B | vs HLN |
| EPCEdgewell Personal Care Company | 28.47 | +3.34% | $1.31B | vs HLN |
| CLColgate-Palmolive Company | 98.71 | +1.89% | $78.47B | vs HLN |
Indexes, lists and sector
Haleon stock FAQ
What is Haleon's stock price today?
HLN last traded at $9.07 as of Nov 20, 4:00 PM EST, up 0.22% on the day. Prices are delayed at least 15 minutes.
Does Haleon pay a dividend?
Yes. Haleon pays $0.073 per share annually, a 0.80% yield. The most recent dividend of $0.064 had an ex-dividend date of Aug 14, 2026.
What is HLN's P/E ratio?
HLN trades at a trailing P/E ratio of 18.51 and a forward P/E of 15.01, compared with a median of 38.4 for its closest peers.
Who is Haleon's CEO?
Mr. Brian James McNamara is the chief executive officer of Haleon plc ADR, which has about 24,535 employees.
What is the HLN 52-week high?
The 52-week high for HLN is $11.28 and the 52-week low is $8.38. The stock is currently 19.6% below its high.